02 Jul 2018 --- Royal DSM has announced the proposed sale of DSM Sinochem Pharmaceuticals (DSP) – a pharmaceutical joint venture with China’s Sinochem Group – to Bain Capital. The move comes days after the Dutch company announced that it is seeking to streamline its portfolio and has set aside about €3 billion to expand its nutrition business. It suggests that further funds will become available for strategic moves within the nutrition arena, as DSM moves further away from its heritage chemical positioning and further cements itself as a leading nutrition powerhouse.
